Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjögren's Syndrome: a randomized, double-blind, placebo controlled cross-over study
2007

Effectiveness of Low-Dose Doxycycline in Sjögren's Syndrome

Sample size: 22 publication Evidence: low

Author Information

Author(s): Hubertus Seitsalo, Raija K Niemelä, Magdalena Marinescu-Gava, Tuija Vuotila, Leo Tjäderhane, Tuula Salo

Primary Institution: University of Oulu

Hypothesis

Low-dose doxycycline could be effective in treating Sjögren's syndrome by decreasing tissue damage and subjective symptoms.

Conclusion

Low-dose doxycycline may not be useful in reducing the primary symptoms of Sjögren's syndrome.

Supporting Evidence

  • The study involved 22 patients who were randomly assigned to receive either the medication or placebo.
  • Seventeen out of 22 patients completed the study and provided data.
  • Statistically significant increases in fatigue were observed with low-dose doxycycline.

Takeaway

The study tested a medicine called low-dose doxycycline to see if it helps people with a condition called Sjögren's syndrome, but it didn't really make a difference.

Methodology

This was a randomized, double-blind, placebo-controlled cross-over study involving 22 patients who received either low-dose doxycycline or placebo for 10 weeks.

Potential Biases

The study was double-blind, reducing bias risks, but the small sample size may limit the reliability of the findings.

Limitations

The study had a small sample size and the subjective symptoms may reflect normal fluctuations rather than true medication effects.

Participant Demographics

All participants were women with primary Sjögren's syndrome.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1477-5751-6-11

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication